Dacula, Hamima .
HRN: 27-98-49 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/28/2025
CEFTAZIDIME 1GM (VIAL)
10/28/2025
11/04/2025
IV
160mg
Q8
Neonatal Penumonia T/c Sepsis
Checking Final Appropriateness